92 related articles for article (PubMed ID: 8834817)
1. Assessment of severity of haemolytic disease of newborn by monocyte monolayer assay.
Dhingra-Kumar N; Duguid JK; Bromilow IM
Indian J Med Res; 1995 Aug; 102():71-6. PubMed ID: 8834817
[TBL] [Abstract][Full Text] [Related]
2. [Functional evaluation of erythrocytic antibodies by photometric detection of erythrophagocytosis in the monocyte monolayer assay].
Cassens U; Garritsen HS; Sibrowski W; Holzgreve W
Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):297-300. PubMed ID: 8766487
[TBL] [Abstract][Full Text] [Related]
3. Antibody dependent cell mediated cytotoxicity and erythrophagocytosis assays in Rh haemolytic disease of the newborn.
Patil JS; Gupte SC
Ceylon Med J; 1996 Jun; 41(2):46-50. PubMed ID: 8771942
[TBL] [Abstract][Full Text] [Related]
4. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn.
Sacks DA; Nance SJ; Garratty G; Petrucha RA; Horenstein J; Fotheringham N
Am J Perinatol; 1993 Nov; 10(6):428-31. PubMed ID: 8267805
[TBL] [Abstract][Full Text] [Related]
5. Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn.
Zupańska B; Brojer E; Richards Y; Lenkiewicz B; Seyfried H; Howell P
Vox Sang; 1989; 56(4):247-53. PubMed ID: 2503936
[TBL] [Abstract][Full Text] [Related]
6. Monocyte monolayer assay (MMA)--an efficient method for predicting the clinical significance of alloantibodies and the severity of hemolytic disease of the newborn.
Garratty G
Beitr Infusionsther; 1988; 21():236-9. PubMed ID: 2462981
[No Abstract] [Full Text] [Related]
7. Results of tests with different cellular bioassays in relation to severity of RhD haemolytic disease. Report from nine collaborating laboratories.
Vox Sang; 1991; 60(4):225-9. PubMed ID: 1926829
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.
Garner SF; Gorick BD; Lai WY; Brown D; Taverner J; Hughes-Jones NC; Contreras M; Lubenko A
Vox Sang; 1995; 68(3):169-76. PubMed ID: 7625074
[TBL] [Abstract][Full Text] [Related]
9. The monocyte monolayer assay: a noninvasive technique for predicting the severity of in utero hemolysis.
Larson PJ; Thorp JM; Miller RC; Hoffman M
Am J Perinatol; 1995 May; 12(3):157-60. PubMed ID: 7612085
[TBL] [Abstract][Full Text] [Related]
10. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).
Dooren MC; Kuijpers RW; Joekes EC; Huiskes E; Goldschmeding R; Overbeeke MA; von dem Borne AE; Engelfriet CP; Ouwehand WH
Lancet; 1992 May; 339(8801):1067-70. PubMed ID: 1349101
[TBL] [Abstract][Full Text] [Related]
11. Role of C1q in Rhesus haemolytic disease of the newborn.
Poorkhorsandi ME; Gupte SC
Indian J Med Res; 1996 Sep; 104():208-12. PubMed ID: 8898479
[TBL] [Abstract][Full Text] [Related]
12. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.
Hadley AG; Kumpel BM; Leader KA; Poole GD; Fraser ID
Br J Haematol; 1991 Feb; 77(2):221-8. PubMed ID: 2004024
[TBL] [Abstract][Full Text] [Related]
13. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test.
Lucas GF; Hadley AG; Nance SJ; Garratty G
Transfusion; 1993 Jun; 33(6):484-7. PubMed ID: 8516790
[TBL] [Abstract][Full Text] [Related]
14. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
[TBL] [Abstract][Full Text] [Related]
15. [New possibilities in diagnosis of hemolytic diseases in newborns].
Fischer K; Poschmann A; Grundmann A; Asmussen S
Infusionsther Transfusionsmed; 1992 Aug; 19(4):208-13. PubMed ID: 1422082
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the monocyte chemiluminescent response to anti-D-sensitized red cells by Fc gamma RI-blocking antibodies which ameliorate the severity of haemolytic disease of the newborn.
Shepard SL; Noble AL; Filbey D; Hadley AG
Vox Sang; 1996; 70(3):157-63. PubMed ID: 8740008
[TBL] [Abstract][Full Text] [Related]
17. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
[TBL] [Abstract][Full Text] [Related]
18. IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?
Brinc D; Le-Tien H; Crow AR; Freedman J; Lazarus AH
Br J Haematol; 2007 Oct; 139(2):275-9. PubMed ID: 17897303
[TBL] [Abstract][Full Text] [Related]
19. High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN.
Neppert J; v Witzleben-Schürholz E; Zupanska B; Bartz L; Greve O; Eichler H; Kerowgan M; Wichmann MG
Eur J Haematol; 1999 Aug; 63(2):120-5. PubMed ID: 10480291
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and functional asessment of anti-RhD: a comparative study of non-invasive methods in antenatal prediction of Rh hemolytic disease.
Filbey D; Garner SF; Hadley AG; Shepard SL
Acta Obstet Gynecol Scand; 1996 Feb; 75(2):102-7. PubMed ID: 8604593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
